Solifenacin in a Flexible Dose Regimen With Tolterodine as an Active Comparator in a Double-Blind, Double-Dummy, Randomised Overactive Bladder Symptom Trial.

Trial Profile

Solifenacin in a Flexible Dose Regimen With Tolterodine as an Active Comparator in a Double-Blind, Double-Dummy, Randomised Overactive Bladder Symptom Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Solifenacin; Tolterodine
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms STAR
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 09 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top